Literature DB >> 24120398

Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach.

P N R Dekhuijzen1, W Vincken, J C Virchow, N Roche, A Agusti, F Lavorini, W M van Aalderen, D Price.   

Abstract

Inhaled medication is the cornerstone of the pharmacological treatment of patients with asthma and COPD. The major two classes of inhaled medication include corticosteroids (ICS) and bronchodilators. There is a wide diversity in molecules in both classes. Moreover, there is a wide variation in delivery systems. The correct use of inhalers is not granted and patients often incur in many mistakes when using pMDIs and DPIs, despite repeated instructions. A better matching between patient and device could be accomplished if the physician is aware of: (1) the patient characteristics (disease, severity, fluctuation in airflow obstruction, etc); (2) what class of medication is indicated; (3) where in the lung the medication should be delivered; and, (4) how this can be best achieved by a given device in this specific patient. We focus on the prescription of pMDIs and DPIs at the GP office or at the outpatient clinic of the hospital, and we propose an evidence based approach enabling the caregiver to make a rational choice in only a few minutes by just considering the following four simple questions: Who?, What? Where? and How? (the so-called 3W-H approach).
Copyright © 2013 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Asthma; COPD; DPI's; Inhaled medication; pMDI's

Mesh:

Substances:

Year:  2013        PMID: 24120398     DOI: 10.1016/j.rmed.2013.09.013

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  27 in total

1.  Study of inhaler technique in asthma patients: differences between pediatric and adult patients.

Authors:  Pablo Manríquez; Ana María Acuña; Luis Muñoz; Alvaro Reyes
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

Review 2.  Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Authors:  Federico Lavorini; Claudia Mannini; Elisa Chellini; Giovanni A Fontana
Journal:  Drugs Aging       Date:  2016-07       Impact factor: 3.923

Review 3.  Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies.

Authors:  Soojin Cho-Reyes; Bartolome R Celli; Carole Dembek; Karen Yeh; Maryam Navaie
Journal:  Chronic Obstr Pulm Dis       Date:  2019-07-24

4.  Inhaler device technique can be improved in older adults through tailored education: findings from a randomised controlled trial.

Authors:  Melanie A Crane; Christine R Jenkins; Dianne P Goeman; Jo A Douglass
Journal:  NPJ Prim Care Respir Med       Date:  2014-09-04       Impact factor: 2.871

5.  The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.

Authors:  A Lewis; S Torvinen; P N R Dekhuijzen; H Chrystyn; A T Watson; M Blackney; A Plich
Journal:  BMC Health Serv Res       Date:  2016-07-12       Impact factor: 2.655

Review 6.  A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?

Authors:  Ronald Dahl; Alan Kaplan
Journal:  BMC Pulm Med       Date:  2016-10-11       Impact factor: 3.317

7.  Knowledge of spacer device, peak flow meter and inhaler technique (MDIs) among health care providers: an evaluation of doctors and nurses.

Authors:  Bamidele O Adeniyi; Ayodeji M Adebayo; Olayinka S Ilesanmi; Daniel O Obaseki; Olubukola O Akinwalere; Gregory E Erhabor
Journal:  Ghana Med J       Date:  2018-03

Review 8.  Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD.

Authors:  Girolamo Pelaia; Alessandro Vatrella; Maria Teresa Busceti; Luca Gallelli; Cecilia Calabrese; Rosa Terracciano; Nicola Lombardo; Rosario Maselli
Journal:  Ther Clin Risk Manag       Date:  2015-10-08       Impact factor: 2.423

9.  Effects of Educational Interventions for Chronic Airway Disease on Primary Care.

Authors:  Jung Yeon Lee; Kwang Ha Yoo; Deog Kyeom Kim; Sang-Ha Kim; Tae-Eun Kim; Tae-Hyung Kim; Chin Kook Rhee; Yong Bum Park; Hyoung Kyu Yoon; Ho-Kee Yum
Journal:  J Korean Med Sci       Date:  2016-05-19       Impact factor: 2.153

Review 10.  Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®).

Authors:  Pieter Nicolaas Richard Dekhuijzen; Federico Lavorini; Omar S Usmani
Journal:  Patient Prefer Adherence       Date:  2016-08-18       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.